BioCentury
ARTICLE | Company News

SuppreMol, University of Regensburg deal

May 23, 2011 7:00 AM UTC

SuppreMol received an option to license an undisclosed antibody against IL-3 from the university. SuppreMol plans on developing the antibody for autoimmune indications. SuppreMol has until year end to...